Get started
666

SICHUAN KELUN-BIOTECH BIOPHARMACEUT

No trades
See on Supercharts
Overview Financials News Discussions Technicals
Forecast
Seasonals

Price target

217.290.000.00%
The 13 analysts offering 1 year price forecasts for 6990 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 18 analysts giving stock ratings to 6990 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Frequently Asked Questions


6990 EPS for the last quarter is 1.51 HKD despite the estimation of −1.16 HKD. In the next quarter EPS is expected to reach −3.06 HKD. Track more of SICHUAN KELUN-BIOTECH BIOPHARMACEUT financials and stay on top of what is up with the company.
In the next quarter SICHUAN KELUN-BIOTECH BIOPHARMACEUT revenue is expected to reach ‪627.23 M‬ HKD. Check out SICHUAN KELUN-BIOTECH BIOPHARMACEUT revenue and earnings and make informed decisions.
According to analysts, 6990 price target is 217.29 HKD with a max estimate of 244.31 HKD and a min estimate of 196.26 HKD. Check if this forecast comes true in a year, meanwhile watch SICHUAN KELUN-BIOTECH BIOPHARMACEUT stock price chart and keep track of the current situation with 6990 news and stock market news.
We've gathered opinions of 18 analysts rating 6990 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.